@article{477be6e3673c4620baa843b79eb92a5f,
title = "First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours",
keywords = "BROMODOMAIN INHIBITION, DOSE-ESCALATION, P-TEFB, RECOMMENDATIONS, LYMPHOMA, CANCER, 3122 Cancers",
author = "Malaka Ameratunga and Irene Brana and Petri Bono and Sophie Postel-Vinay and Ruth Plummer and John Aspegren and Timo Korjamo and Amir Snapir and {de Bono}, {Johann S.}",
year = "2020",
month = dec,
day = "8",
doi = "10.1038/s41416-020-01077-z",
language = "English",
volume = "123",
pages = "1730--1736",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "12",
}